CAS 1855871-76-9

(2S)-2-amino-4-[<em>bis</em>[[2-[(3-methylphenyl)methoxy]phenyl]methyl]amino]-butanoic acid

CAS : 1855871-76-9

Formule : C₃₄H₃₈N₂O₄

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 538.6765

Ref: IN-DA01LIRW

V-9302

CAS : 1855871-76-9

V-9302

Degré de pureté : ≥98%

Masse moléculaire : 538.68g/mol

Ref: 54-BUP06141

V-9302

CAS : 1855871-76-9

V-9302 is a drug that inhibits the growth of cancer cells. It is a member of the sorafenib family and acts as an inhibitor of fatty acid synthase (FAS) and Vaspin, which are pro-apoptotic proteins. V-9302 has been shown to inhibit protein synthesis in vitro by binding to ribosomes, and also binds to various proteins in colorectal adenocarcinoma cells. V-9302 has shown efficacy against myeloid leukemia cell lines in vitro, but not against fetal bovine or normal human erythrocytes.

Formule : C₃₄H₃₈N₂O₄

Degré de pureté : Min. 95%

Masse moléculaire : 538.68 g/mol

Ref: 3D-FZC87176

V-9302

CAS : 1855871-76-9

V-9302 (V9302) is a competitive antagonist of transmembrane glutamine flux that selectively and potently targets the amino acid transporter ASCT2 (IC50: 9.6 uM

Formule : C₃₄H₃₈N₂O₄

Degré de pureté : 98% - 99.54%

Couleur et forme : Solid

Masse moléculaire : 538.68

Ref: TM-T5345